American Federation for Aging Research (AFAR) is a company within the Non-Profit Organization category. The American Federation for Aging Research (AFAR) is a national non-profit organization that supports and advances healthy aging through biomedical research. Since its inception, it has focused on funding early-career scientists and pioneering research into the fundamental biological processes of aging to prevent age-related diseases.
American Federation for Aging Research (AFAR) was founded in 1981 and is headquartered in New York, NY.
American Federation for Aging Research (AFAR) is rated Contender on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for American Federation for Aging Research (AFAR) is Moderate. Significant factual deltas detected. Inconsistent representation across models.
AI models classify American Federation for Aging Research (AFAR) as a Challenger. AI names competitors first.
American Federation for Aging Research (AFAR) appeared in 5 of 8 sampled buyer-intent queries (63%). AFAR dominates queries specifically mentioning 'aging research' and 'geroscience grants' but loses visibility to newer longevity startups and the NIA for broader queries like 'how to fund longevity research'.
AFAR is accurately perceived as a legacy authority in geroscience. However, its specific current grant portfolio and recent clinical trial involvements (like TAME) are often described using several-year-old data. Key gap: The distinction between AFAR (the funding body) and AFAR (the travel magazine) can occasionally lead to mixed semantic signals in retrieval-augmented prompts.
Of 5 key facts verified about American Federation for Aging Research (AFAR), 3 are well-documented (likely accurate across AI models), 2 have limited sourcing, and 0 are retrieval-dependent and may be inaccurate without live search.
Current leadership transitions or specific board member changes are often outdated in AI training data.
Buyers turn to American Federation for Aging Research (AFAR) for Manual Research Tracking: Conducting independent literature reviews of geroscience without centralized funding guidance., Generic Academic Funding: Allowing researchers to seek general biomedical funding without specialized geroscience support., among 2 documented problem areas.
Buyers evaluating American Federation for Aging Research (AFAR) typically ask AI models about "best grants for geroscience research", "biology of aging research organizations", "longevity biotech startup funding", and 4 similar queries.
American Federation for Aging Research (AFAR)'s main competitors are National Institute on Aging (NIA). According to AI models, these are the brands most frequently named alongside American Federation for Aging Research (AFAR) in buyer-intent queries.
American Federation for Aging Research (AFAR)'s core products are Grants (Beeson Scholars, Glenn Foundation Discovery Awards), Scientific Conferences, Geroscience Advocacy.
American Federation for Aging Research (AFAR) uses Enterprise/Custom.
American Federation for Aging Research (AFAR) serves Biomedical Researchers, Academic Institutions, Philanthropic Donors, Government Health Agencies.
American Federation for Aging Research (AFAR) AFAR is the only national non-profit specifically focused on the *biology* of aging for the purpose of extending healthspan rather than focusing on a single disease.
Brand Authority Index (BAI) tier: Contender (exact score locked for unclaimed brands)
Archetype: Challenger
https://optimly.ai/brand/american-federation-for-aging-research-afar
Last analyzed: April 10, 2026
Founded: 1981
Headquarters: New York, NY